何氏眼科
(301103)
| 流通市值：16.42亿 | | | 总市值：31.23亿 |
| 流通股本：8309.01万 | | | 总股本：1.58亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 864,900,603.72 | 584,757,474.76 | 284,795,525.11 | 1,185,231,535.43 |
| 营业收入 | 864,900,603.72 | 584,757,474.76 | 284,795,525.11 | 1,185,231,535.43 |
| 二、营业总成本 | 820,811,241.56 | 537,327,702.87 | 246,017,043.14 | 1,086,814,283.25 |
| 营业成本 | 510,958,886.04 | 339,405,846.06 | 160,247,293.04 | 690,284,215.83 |
| 税金及附加 | 4,623,931.5 | 2,704,010.4 | 1,319,692.15 | 7,025,090.81 |
| 销售费用 | 133,215,308.06 | 88,130,582.43 | 39,004,361.4 | 177,973,546.11 |
| 管理费用 | 162,215,804.62 | 108,177,561.58 | 48,914,804.77 | 214,304,385.81 |
| 研发费用 | 13,724,401.11 | 4,675,739.4 | 2,428,194.82 | 12,623,576.49 |
| 财务费用 | -3,927,089.77 | -5,766,037 | -5,897,303.04 | -15,396,531.8 |
| 其中:利息费用 | 8,491,577.98 | 5,654,090.61 | 2,879,392.79 | 13,603,417.08 |
| 其中:利息收入 | 14,409,261.75 | 12,706,224.36 | 9,433,029.62 | 31,751,488.43 |
| 加:公允价值变动收益 | 92,925 | - | - | - |
| 加:投资收益 | 741.66 | - | - | 3,167,739.49 |
| 资产处置收益 | 1,304,915.9 | 25,105.48 | 23,186.09 | 3,528,059.24 |
| 资产减值损失(新) | -676,466.41 | -1,253,171.95 | -1,175,567.71 | -1,215,692.79 |
| 信用减值损失(新) | -565,375.39 | -753,900.49 | -1,023,178.52 | -2,488,987.94 |
| 其他收益 | 3,029,943.12 | 2,090,258.92 | 1,380,323.13 | 5,253,561.43 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 47,276,046.04 | 47,538,063.85 | 37,983,244.96 | 106,661,931.61 |
| 加:营业外收入 | 153,113.5 | 61,201.73 | 15,785.84 | 843,186.04 |
| 减:营业外支出 | 2,294,242.84 | 2,026,022.54 | 201,775.77 | 2,125,005.23 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 45,134,916.7 | 45,573,243.04 | 37,797,255.03 | 105,380,112.42 |
| 减:所得税费用 | 34,603,309.2 | 25,229,878.92 | 10,614,924.08 | 47,590,126.93 |
| 六、净利润 | 10,531,607.5 | 20,343,364.12 | 27,182,330.95 | 57,789,985.49 |
| 持续经营净利润 | 10,531,607.5 | 20,343,364.12 | 27,182,330.95 | 57,789,985.49 |
| 归属于母公司股东的净利润 | 16,375,500.3 | 24,063,967.54 | 28,976,245.02 | 63,551,557.35 |
| 少数股东损益 | -5,843,892.8 | -3,720,603.42 | -1,793,914.07 | -5,761,571.86 |
| (一)基本每股收益 | 0.1 | 0.15 | 0.18 | 0.4 |
| (二)稀释每股收益 | 0.1 | 0.15 | 0.18 | 0.4 |
| 八、其他综合收益 | 72,240.81 | 1,059.74 | -58.02 | 787.59 |
| 归属于母公司股东的其他综合收益 | 72,240.81 | 1,059.74 | -58.02 | 787.59 |
| 九、综合收益总额 | 10,603,848.31 | 20,344,423.86 | 27,182,272.93 | 57,790,773.08 |
| 归属于母公司股东的综合收益总额 | 16,447,741.11 | 24,065,027.28 | 28,976,187 | 63,552,344.94 |
| 归属于少数股东的综合收益总额 | -5,843,892.8 | -3,720,603.42 | -1,793,914.07 | -5,761,571.86 |
| 公告日期 | 2024-10-29 | 2024-08-30 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |